» Articles » PMID: 25647629

Drug Transporters in the Central Nervous System

Overview
Specialty Pharmacology
Date 2015 Feb 4
PMID 25647629
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Drug targets in the central nervous system (CNS) are numerous and important for drug therapy, e.g., of epilepsy or pain. Drugs and other xenobiotics as well as nutrients cannot freely cross the blood-brain barrier or freely enter cells across plasma membranes and therefore require transport systems. This overview summarizes the current knowledge on the expression of drug transporters in barriers shielding the CNS from the systemic circulation and as such controlling the pharmacokinetics of drugs in the CNS. The main drug transporter families covered are SLCO, SCL22A, ABCB, and ABCC, as genes of these families code for numerous drug transporters. While knowledge on messenger RNA expression in humans, rats, and mice is remarkable, there is clearly a gap in knowledge on the subcellular expression of transporters in specific cells in the CNS and in the barriers shielding the CNS from the systemic circulation. Recent methodologic developments including synthesis of drugs and endogenous substances for imaging will in the future allow the investigation of the function and physiologic role of transporters in the CNS including difficult-to-access systems such as the choroid plexus.

Citing Articles

MiRNAs: main players of cancer drug resistance target ABC transporters.

Mohammadi F, Nejatollahi M, Sheikhnia F, Ebrahimi Y, Mohammadi M, Rashidi V Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39808313 DOI: 10.1007/s00210-024-03719-y.


Impact of Peptide Transport and Memory Function in the Brain.

Cheng L, Shi C, Li X, Matsui T Nutrients. 2024; 16(17).

PMID: 39275263 PMC: 11396983. DOI: 10.3390/nu16172947.


Metabolite transport across central nervous system barriers.

Carstens G, Verbeek M, Rohlwink U, Figaji A, Te Brake L, van Laarhoven A J Cereb Blood Flow Metab. 2024; 44(7):1063-1077.

PMID: 38546534 PMC: 11179608. DOI: 10.1177/0271678X241241908.


ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.

Singh H, Dhotre K, Shyamveer , Choudhari R, Verma A, Mahajan S Mol Genet Genomic Med. 2024; 12(3):e2362.

PMID: 38451012 PMC: 10955225. DOI: 10.1002/mgg3.2362.


The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers.

Mineiro R, Albuquerque T, Neves A, Santos C, Costa D, Quintela T Int J Mol Sci. 2023; 24(16).

PMID: 37628722 PMC: 10454916. DOI: 10.3390/ijms241612541.


References
1.
Young J, Yao S, Sun L, Cass C, Baldwin S . Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 2008; 38(7-8):995-1021. DOI: 10.1080/00498250801927427. View

2.
Ashraf T, Kao A, Bendayan R . Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS. Adv Pharmacol. 2014; 71:45-111. DOI: 10.1016/bs.apha.2014.06.010. View

3.
Kell D, Dobson P, Oliver S . Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discov Today. 2011; 16(15-16):704-14. DOI: 10.1016/j.drudis.2011.05.010. View

4.
Saunders N, Daneman R, Dziegielewska K, Liddelow S . Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol Aspects Med. 2013; 34(2-3):742-52. DOI: 10.1016/j.mam.2012.11.006. View

5.
Agarwal S, Uchida Y, Mittapalli R, Sane R, Terasaki T, Elmquist W . Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice. Drug Metab Dispos. 2012; 40(6):1164-9. PMC: 3362790. DOI: 10.1124/dmd.112.044719. View